Turkish Journal of Medical Sciences
Abstract
Endocrine-disrupting chemicals (EDCs) are compounds that interfere with hormone synthesis, secretion, metabolism, or excretion. Evidence indicates that increased exposure to EDCs is associated with insulin resistance and, most notably, type 2 diabetes worldwide. This suggests a diabetogenic effect that is independent of obesity, underscoring the complex mechanisms and broad impact of EDCs on metabolic health. Key pathways include hormone mimicry and antagonism, altered hormone metabolism, inflammatory responses, and mitochondrial dysfunction. This review summarises the mechanisms through which EDCs contribute to these conditions and evaluates the epidemiological and experimental evidence supporting these associations.
Author ORCID Identifier
MERİÇMERIÇ COŞKUN: 0000-0003-4855-6078
ETHEM CERİT: 0000-0002-7518-388X
TUĞBA BARLAS: 0000-0003-0042-6928
ALEV EROĞLU ALTINOVAALTINOVA: 0000-0002-6707-7761
DOI
10.55730/1300-0144.6119
Keywords
diabetes, Endocrine disruptors, insulin resistance, T2D
First Page
1595
Last Page
1601
Publisher
The Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
COŞKUN, M, CERİT, E. T, BARLAS, T, & ALTINOVA, A. E (2025). Endocrine disruptors, insulin resistance, and diabetes. Turkish Journal of Medical Sciences 55 (7): 1595-1601. https://doi.org/10.55730/1300-0144.6119